Publicacións en colaboración con investigadores/as de Hospital de Fuenlabrada (21)

2024

  1. Patients who suffer a first atherosclerotic cardiovascular event while taking statins are often far off of lipid targets

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 34, Núm. 1, pp. 90-97

  2. Surgery for inflammatory bowel disease in Spain: How are we doing? Initial results of a nationwide prospective registry

    Cirugia Espanola

2023

  1. Factors associated with the need of parenteral nutrition in critically ill patients after the initiation of enteral nutrition therapy

    Frontiers in Nutrition, Vol. 10

  2. Impact of Advanced Age on the Incidence of Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stable Coronary Artery Disease in a Real-World Setting in Spain

    Journal of Clinical Medicine, Vol. 12, Núm. 16

  3. Sensitization to isothiazolinones in the Spanish Contact Dermatitis Registry (REIDAC): 2019–2021 epidemiological situation

    Contact Dermatitis, Vol. 88, Núm. 3, pp. 212-219

2022

  1. Assessment of medical management in Coronary Type 2 Diabetic patients with previous percutaneous coronary intervention in Spain: A retrospective analysis of electronic health records using Natural Language Processing

    PLoS ONE, Vol. 17, Núm. 2 February

  2. Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (J. Clin. Med., (2021), 10, (2885), 10.3390/jcm10132885)

    Journal of Clinical Medicine

  3. Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases*

    British Journal of Dermatology, Vol. 186, Núm. 1, pp. 142-152

  4. Major Adverse Cardiovascular Events in Coronary Type 2 Diabetic Patients: Identification of Associated Factors Using Electronic Health Records and Natural Language Processing

    Journal of Clinical Medicine, Vol. 11, Núm. 20

2021

  1. Impact of covid-19 on patients in radiotherapy oncology departaments in Spain

    Radiotherapy and Oncology

  2. MAB-MIG: registry of the spanish neurological society of erenumab for migraine prevention

    Journal of Headache and Pain, Vol. 22, Núm. 1

  3. Multiple Perianal Ulcers Related to Use of a Hemorrhoidal Ointment With the Active Ingredients Triamcinolone Acetonide, Lidocaine, and Pentosan Polysulfate Sodium: A Series of 11 Spanish Patients

    Actas Dermo-Sifiliograficas, Vol. 112, Núm. 7, pp. 654-660

  4. Should methyldibromo glutaronitrile continue to be used in the European baseline Series? A REIDAC national cross-sectional study

    Contact dermatitis, Vol. 85, Núm. 5, pp. 572-577

2020

  1. Recommendations for specialized nutritional-metabolic management of the critical patient: introduction, methodology and list of recommendations. Metabolism and Nutrition Working Group of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC)

    Medicina Intensiva, Vol. 44, pp. 1-14

2019

  1. Ige-mediated sensitization to galactose-α-1,3-galactose (α-gal) in urticaria and anaphylaxis in spain: Geographical variations and risk factors

    Journal of Investigational Allergology and Clinical Immunology, Vol. 29, Núm. 6, pp. 436-443

2017

  1. La Medicina Interna del siglo XXI: estándares de organización y funcionamiento

    Revista Clinica Espanola, Vol. 217, Núm. 9, pp. 526-533

  2. RECALMIN: The association between management of Spanish National Health Service Internal Medical Units and health outcomes

    International Journal for Quality in Health Care, Vol. 29, Núm. 4, pp. 507-511

2016

  1. Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome

    Critical Care, Vol. 20, Núm. 1

  2. RECALMIN. La atención al paciente en las unidades de Medicina Interna del Sistema Nacional de Salud

    Revista Clinica Espanola, Vol. 216, Núm. 4, pp. 175-182

2012

  1. Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: The ANIMO study

    Movement Disorders, Vol. 27, Núm. 2, pp. 211-218